Clinical Trials Open to People Under 18
(157 trials open to new patients)

• Acute Lymphoblastic Leukemia (18 open to new patients)
• Acute Myeloid Leukemia (10 open to new patients)
• Adrenal Gland Pheochromocytoma (1 open to new patients)
• Adrenal Insufficiency (1 open to new patients)
• Alpha Thalassemia (1 open to new patients)
• Alpha Thalassemia Major (1 open to new patients)
• Anal Cancer (1 open to new patients)
• Anaplastic Ganglioglioma (1 open to new patients)
• Anaplastic Pleomorphic Xanthoastrocytoma (1 open to new patients)
• Anemia (8 open to new patients)
• Angiolipoma (1 open to new patients)
• Angioma (1 open to new patients)
• Arrythmia (1 open to new patients)
• Arthralgia (1 open to new patients)
• Asthma (1 open to new patients)
• Astrocytoma (10 open to new patients)
• Atrial Septal Defect (1 open to new patients)
• Attention-Deficit/Hyperactivity Disorder (1 open to new patients)
• Atypical Teratoid Rhabdoid Tumor (1 open to new patients)
• Autism (1 open to new patients)
• Autoimmune Disease (1 open to new patients)
• Bone Marrow Transplant (2 open to new patients)
• Brain Tumor (9 open to new patients)
• Breast Cancer (2 open to new patients)
• Bronchopulmonary Dysplasia (3 open to new patients)
• Cancer, General (3 open to new patients)
• Carcinoma In Situ (2 open to new patients)
• Cardiotoxicity (1 open to new patients)
• Cardiovascular Risk Factor (1 open to new patients)
• Cavernous Hemangioma (1 open to new patients)
• Central Nervous System Embryonal Tumor (1 open to new patients)
• Central Nervous System Neoplasms (5 open to new patients)
• Central Nervous System Tumor (2 open to new patients)
• Cerebral Cavernous Malformation (1 open to new patients)
• Cerebral Palsy (1 open to new patients)
• Chordoma (1 open to new patients)
• Choriocarcinoma (2 open to new patients)
• Chronic Kidney Disease (1 open to new patients)
• Chronic Lung Disease of Prematurity (1 open to new patients)
• Chronic Myeloid Leukemia (1 open to new patients)
• CNS Tumor (1 open to new patients)
• Coagulation Disorder (1 open to new patients)
• Colon Cancer (1 open to new patients)
• Colorectal Cancer (2 open to new patients)
• COVID-19 (3 open to new patients)
• Cystic Nephroma (1 open to new patients)
• Desmoid-Type Fibromatosis (1 open to new patients)
• Desmoplastic Small Round Cell Tumor (1 open to new patients)
• Disorders of the Immune System (1 open to new patients)
• Down Syndrome (4 open to new patients)
• Dysplasia (6 open to new patients)
• Ectomesenchymoma (1 open to new patients)
• Edema (1 open to new patients)
• Endometrial Cancer (2 open to new patients)
• Ependymal Tumor (1 open to new patients)
• Ependymoma (12 open to new patients)
• Epilepsy (1 open to new patients)
• Ewing Sarcoma (15 open to new patients)
• Exercise (1 open to new patients)
• Extragonadal Embryonal Carcinoma (1 open to new patients)
• Eye Cancer (1 open to new patients)
• Facial Angiofibroma (1 open to new patients)
• Fallopian Tube Cancer (1 open to new patients)
• Fibrolamellar Carcinoma (1 open to new patients)
• Ganglioneuroblastoma (3 open to new patients)
• Genetic Inborn Errors of Metabolism (1 open to new patients)
• Germ Cell Tumor (15 open to new patients)
• Glioblastoma (8 open to new patients)
• Glioma (32 open to new patients)
• Gliosis (1 open to new patients)
• Graft Versus Host Disease (1 open to new patients)
• Growth Failure (1 open to new patients)
• Head and Neck Cancer (1 open to new patients)
• Head and Neck Squamous Cell Carcinoma (1 open to new patients)
• Heart Failure (2 open to new patients)
• Hematologic Malignancies (2 open to new patients)
• Hematological Malignancies (1 open to new patients)
• Hematopoietic and Lymphoid Cell Neoplasm (4 open to new patients)
• Hematopoietic and Lymphoid System Neoplasm (1 open to new patients)
• Hematopoietic Cell Transplantation (3 open to new patients)
• Hemimegalencephaly (1 open to new patients)
• Hemispheric (1 open to new patients)
• Hemoglobinopathy (2 open to new patients)
• Hemophilia (1 open to new patients)
• Hepatoblastoma (13 open to new patients)
• Hepatocellular Carcinoma (1 open to new patients)
• High Blood Pressure (2 open to new patients)
• Histiocytic and Dendritic Cell Neoplasm (2 open to new patients)
• Histiocytic Disorders (1 open to new patients)
• HIV/AIDS (1 open to new patients)
• HLA-A*0201 Positive Cells Present (1 open to new patients)
• Hodgkin's Lymphoma (20 open to new patients)
• Hydrops Fetalis (1 open to new patients)
• Hyperphosphatemia (1 open to new patients)
• Hypokalemia (1 open to new patients)
• IDH1 Gene Mutation (1 open to new patients)
• IDH2 Gene Mutation (1 open to new patients)
• Immunodeficiency (1 open to new patients)
• Immunotherapy (3 open to new patients)
• Infantile Fibrosarcoma (1 open to new patients)
• Inherited Abnormalities of Platelets (1 open to new patients)
• Inherited Disorders of Metabolism (1 open to new patients)
• INI1-negative Tumors (1 open to new patients)
• Insomnia (1 open to new patients)
• Intracranial Neoplasm (1 open to new patients)
• Intraventricular Hemorrhage (1 open to new patients)
• Juvenile Xanthogranuloma (1 open to new patients)
• Kawasaki Disease (1 open to new patients)
• Kidney Cancer (2 open to new patients)
• Kidney Disease (1 open to new patients)
• Kidney Medullary Carcinoma (1 open to new patients)
• Kidney Neoplasm (1 open to new patients)
• Kidney Oncocytoma (1 open to new patients)
• Langerhans Cell Histiocytosis (13 open to new patients)
• Leukemia (29 open to new patients)
• Liver Cancer (1 open to new patients)
• Locally Advanced Chordoma (1 open to new patients)
• Lung Cancer (5 open to new patients)
• Lung Non-Small Cell Carcinoma (1 open to new patients)
• Lung Non-Squamous Non-Small Cell Carcinoma (1 open to new patients)
• Lymphoid Malignancies (1 open to new patients)
• Lymphoma (31 open to new patients)
• Lymphoproliferative Disorder (1 open to new patients)
• Macrocephaly (1 open to new patients)
• Malignancies (1 open to new patients)
• Malignant Germ Cell Neoplasm (1 open to new patients)
• Malignant Neoplasm (8 open to new patients)
• Malignant Rhabdoid Tumor (1 open to new patients)
• Malignant Solid Neoplasm (16 open to new patients)
• MAPK1 Gene Mutation (1 open to new patients)
• Medulloblastoma (15 open to new patients)
• Melanoma (3 open to new patients)
• Menorrhagia (1 open to new patients)
• Mesoblastic Nephroma (2 open to new patients)
• Metanephric Adenofibroma (1 open to new patients)
• Metanephric Adenoma (1 open to new patients)
• Metanephric Stromal Tumor (1 open to new patients)
• Metanephric Tumor (1 open to new patients)
• Metastatic Chordoma (1 open to new patients)
• Metastatic Malignant Solid Neoplasm (1 open to new patients)
• Movement Disorders (1 open to new patients)
• Multiple Myeloma (1 open to new patients)
• Myelodysplastic Syndrome (3 open to new patients)
• Myeloproliferative Neoplasms (2 open to new patients)
• Necrotizing Enterocolitis (1 open to new patients)
• Neoplasms (8 open to new patients)
• Neuroblastoma (29 open to new patients)
• Neuroectodermal Tumors (1 open to new patients)
• Neurofibromatosis (3 open to new patients)
• Newborn (1 open to new patients)
• Non Hodgkin Lymphoma (17 open to new patients)
• Non-Small Cell Lung Cancer (4 open to new patients)
• Nonmalignant Diseases (1 open to new patients)
• NY-ESO-1 Positive (1 open to new patients)
• Obesity (1 open to new patients)
• Ossifying Renal Tumor of Infancy (1 open to new patients)
• Osteoid Osteoma (1 open to new patients)
• Osteosarcoma (14 open to new patients)
• Ovarian Cancer (1 open to new patients)
• Ovarian Embryonal Carcinoma (1 open to new patients)
• Ovarian Tumor (2 open to new patients)
• Pain (1 open to new patients)
• Pediatric Cancer (2 open to new patients)
• Peritoneal Cancer (1 open to new patients)
• Plexiform Neurofibroma (1 open to new patients)
• Pneumonia (1 open to new patients)
• Polymicrogyria (1 open to new patients)
• Port-Wine Stain (1 open to new patients)
• Postmenopausal (1 open to new patients)
• Postoperative Pain (1 open to new patients)
• Premature Infant (2 open to new patients)
• Primary Central Nervous System Neoplasm (5 open to new patients)
• Primary CNS Tumors (1 open to new patients)
• Primary Hyperaldosteronism (1 open to new patients)
• Primary Malignant Central Nervous System Neoplasm (1 open to new patients)
• Primitive Neuroectodermal Tumor (12 open to new patients)
• PTEN (1 open to new patients)
• PTEN Hamartoma Tumor Syndrome (1 open to new patients)
• Pulmonary Arterial Hypertension (1 open to new patients)
• Rasmussen Encephalitis (1 open to new patients)
• Refractory Adrenal Gland Pheochromocytoma (1 open to new patients)
• Refractory Ganglioneuroblastoma (1 open to new patients)
• Refractory Hepatoblastoma (9 open to new patients)
• Refractory Malignant Solid Neoplasm (11 open to new patients)
• Refractory Osteosarcoma (9 open to new patients)
• Refractory Thyroid Gland Carcinoma (1 open to new patients)
• Renal Cell Carcinoma (2 open to new patients)
• Retinopathy of Prematurity (1 open to new patients)
• Rhabdoid Tumor (16 open to new patients)
• Rhabdomyosarcoma (17 open to new patients)
• Rosacea (1 open to new patients)
• Sarcoma (20 open to new patients)
• Seizures (1 open to new patients)
• Seminoma (2 open to new patients)
• Sickle Cell Anemia (5 open to new patients)
• Skin Cancer/Melanoma (3 open to new patients)
• Skin Infection (1 open to new patients)
• Sleep Disorders (1 open to new patients)
• Soft Tissue Sarcoma (14 open to new patients)
• Solid Neoplasm (2 open to new patients)
• Solid Tumor (29 open to new patients)
• Spinal Column Tumor (1 open to new patients)
• Squamous Cell Carcinoma (2 open to new patients)
• Stroke (1 open to new patients)
• Stromal Neoplasm (1 open to new patients)
• Sturge-Weber Syndrome (1 open to new patients)
• Synovial Sarcoma (2 open to new patients)
• T Cell Lymphoma (1 open to new patients)
• Telangiectasia (1 open to new patients)
• Teratoma (3 open to new patients)
• Testicular Cancer (1 open to new patients)
• Testicular Tumor (1 open to new patients)
• Thalassemia (1 open to new patients)
• Thyroid Cancer (2 open to new patients)
• Thyroid Gland Carcinoma (1 open to new patients)
• Transitional Cell Carcinoma (1 open to new patients)
• Tuberous Sclerosis (2 open to new patients)
• Unresectable Chordoma (1 open to new patients)
• Urinary Tract Infection (1 open to new patients)
• Uterine Cancer (1 open to new patients)
• Vaccine (1 open to new patients)
• Weight Management (1 open to new patients)
• Wilms Tumor (14 open to new patients)